EBV-specific cytotoxic T lymphocytes
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for EBV-specific cytotoxic T lymphocytes, covering 2012-07-30 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection [Phase 2]